Economic of innovation

Petit P. (1995). Employment and technological change. In Handbook of the economics of innovation and technological change, ed. Stoneman, P. Oxford Blackwell. 

Explicitly, I look at how people interact around iterations of representations—or, in plain English, how people behave around versions of models. That behavior is the essence of innovation. This begs a simple proposition when we transform the economics of modeling, prototyping, and simulation, we inherently transform the economics of innovation. Make modeling faster, cheaper, and easier and we surely change the economics of innovation. We incent different iterative and innovative behaviors. 

We can now address the significance of a third element— what can be described as the entrepreneurial, combined element. The six stages of the R D system process are really the steps that characterize going from invention to innovation, as discussed in the economics of innovation literature. The role of the concept of the entrepreneur is very crucial here. 

Innovation and U.S. Research, ACS Symposium Series, The Economics of Innovation, Chapter 7 (1980). 

Geroski, Paul. Markets for Technology. In Handbook of the Economics of Innovation and Technology Change, edited by... 

Cohen, Wesley (1995), Empirical Studies of Innovative Activity, in Paul Stoneman, ed.. Handbook of the Economics of Innovation and Technological Change, Oxford, Basil Blackwell. 

Arundel, A. and A. Geuna. 2004. Proximity and the use of public science by innovative European firms. Forthcoming in Economics of Innovation and new Technology. 

Feldman M.P. 1999. The new economics of innovation, spillovers and agglomeration a review of empirical studies. Economics of Innovation and New Technology, 8 5-25. 

Grupp, H. (1998). Foundations of the Economics of Innovation. Cheltenham Edward Elgar. 

Watu Wamae holds a PhD in the economics of innovation and development and is a visiting research fellow in the Department of Economics,... 

Antonelli, Christiano, 1998, The Dynamics of Localized Technological Changes The Interaction Between Factor Costs Inducement, Demand Pull and Schumpeterian Rivalry, Economics of Innovation and New Technologies 6, 97-120. 

Cowan, Robin, William Cowan, 1998a, On Clustering in the Location of R D Statics and Dynamics, Economics of Innovation and New Technology 6, 201-229. 

Economic growth ultimately depends on the production of new ideas, yet a competitive market is unable to offer suitable incentives for the production of such ideas.2 Patents are not the only mechanism that society has developed to meet this need for new ideas governments have attempted to promote the production of innovation by means of public subsidies. However, both these instruments give rise to inefficiencies, as we will see below. 

Matutes, C., P. Regibeau and K. Rockett (1996), Optimal patent design and the diffusion of innovations , Rand Journal of Economics, 27, pp. 60-83. 

The probability of expansion of a therapeutic innovation shows a positive relationship with the degree of innovation it incorporates, the age of the molecule, the size of the laboratory, the economic results obtained from the product and its previous authorization in the UK. 

Hence, the need for new perspectives has been called for in the study of the adoption and diffusion of sustainable agriculture, with focus on access to, and quality of information (Lovejoy and Napier 1986), the perception of innovations, and the institutional and economic factors related to adoption (Alonge and Martine 1995). Some studies have concluded that it is likely that the successful adoption of conservation practices would be influenced more by a farmers attitude and perception, than any other factor (Alonge and Martine 1995). 

Product failures, on the other hand, become a fixed cost to the company and must be recovered through higher prices for other products if the firm is to remain viable. Thus, there is an increased incentive to avoid the economic uncertainty of innovation. 

This type of constructive impact of TSCA was viewed somewhat differently by Exxon Chemical Company s C.W. Umland. His review of nearly three years of premanufacturing notification cited evidence which suggests substantial disruption of new chemical development and introduction to the market. This disruption was traced to higher research and development costs at an economically vulnerable point in the life cycle of innovative products. A more appropriate balance between opportunity for economic viability and protection from unreasonable... 

Direct and indirect costs are compared public and private costs are estimated at 3.5-4 times those for EPA in 1981. Among the former is loss of innovation. While several studies of this factor have been made for the industry, their reliability is questioned, due in part to lack of sound data prior to 1976. No mention was made of economic trends affecting corporate expenditures for research and development, or of trends in the maturation of industrial chemistry itself. Other indirect costs, such as concentration of manufacture within the industry, may result from costs of compliance, especially for smaller manufacturers. These factors were not compared with extrinsic factors, such as shifts in feedstock supply and commodity manufacture from the United States to other countries. 

DiMasi, J.A., Hansen, R.W. and Grabowski, H.G. (2003) The price of innovation new estimates of drug development costs. Journal of Health Economics, 22, 151-185. 

The following sections of this paper examine the economic characteristics of the R D process in pharmaceuticals that make patents so crihcal. Sections 30.2 to 30.4 discuss the costs of innovation in pharmaceuhcals and the effects on innovative and imitative competition of the 1984 Hatch-Waxman Act. Section 30.5 considers whether the biotech industry is different from the pharmaceuhcal industry in terms of R D costs. Section 30.6 considers the distribution of returns on R D in these industries. The final section presents conclusions and policy considerations. 

As long as no agreement can be achieved in public about the limits of burdens of evidence and/or about the realistic extent or principal limitations of scientific knowledge of the effects of chemicals, there will be repeated attempts to prevent any type of innovation using the irrefutable claim as to uncertainty and lack of knowledge . Innovation and risk are, however, inseparably interlinked. Not only economic and technical, but also social, health and ecological risks are always... 

The SubChem project is concerned with preventing and reducing (eco)toxicological risks as a function of innovation within the scope of sustainable economic activity . The processes of hazardous substance substitution are at the centre of interest . They are examined as innovation processes, or to be more precise, as more or less targeted innovation processes committed to environment and health values. 

How can economic actors achieve greater certainty in orientation avoiding hazardous substances (direction of innovation) ... 

---